Accueil   Diary - News   All news Synthelis & Sanofi Pasteur sign a partnership agreement

Synthelis & Sanofi Pasteur sign a partnership agreement

 

 

                             

 

Synthelis announces the signature of a Partnership with Sanofi Pasteur

 

 

 

After a three year period where Sanofi evaluated Synthelis’ cell-free technology as a potential key enabling technology to develop some of the next generation vaccines, this interest is now confirmed. Both entities established indeed a collaborative program to adapt the protein expression system to the industrial requirements of the vaccine industry

 

“We are very glad to have reached this step with a client like Sanofi Pasteur. We were in a supplier – client relationship since 2011, we are now starting a co-development phase together which will strongly enhanced the added value of Synthelis’ technology and know-how” says Bruno Tillier, President, co-founder of Synthelis.